Self-Selection Studies Need Room To Evaluate Purchase Decisions - Expert
This article was originally published in The Pink Sheet Daily
Executive Summary
The division between product selection and purchase decisions is not as distinct as FDA suggests in the recent draft guidance on designing self-selection studies to support Rx-to-OTC switches, PEGUS Research's McCammon says
You may also be interested in...
Crestor Indication Grows User Pool, But Self-Selection Hinders Statin Switch
Switching statins OTC will require comprehensive consumer education to enable self-selection and flexibility from FDA on the types of information it considers product labeling
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.